Francis Patrick Ostronic - 28 Jan 2022 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role: Director
Signature: /s/ Francis Patrick Ostronic
Issuer symbol: CYTH
Transactions as of: 28 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 01 Feb 2022, 08:24:27 UTC
Previous filing: 24 Jan 2022
Next filing: 04 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTH	Common Stock	Award	$0	+5,065	+4.5%	$0.000000	118,276	28 Jan 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2021. The number of shares received in lieu of cash was calculated based on the closing price of 3.62 per share of common stock on January 28, 2022.

Content

Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2021. The number of shares received in lieu of cash was calculated based on the closing price of 3.62 per share of common stock on January 28, 2022.